@inbook{d30b3246c28a48c9a75a772f9f5ab83d,
title = "The GLP-1 receptor agonist liraglutide improves glucose tolerance and reduces body weight in schizophrenia spectrum disorder patients treated with clozapine or olanzapine",
author = "Louise Vedtofte and Larsen, {Julie R.} and Jakobsen, {Mathilde S. L.} and Jespersen, {Hans R.} and Jakobsen, {Michelle I.} and Svensson, {Camilla K.} and Kamuran Koyuncu and Ole Schjerning and Oturai, {Peter S.} and Andreas Kjaer and Jimmi Nielsen and Holst, {Jens J.} and Ekstr{\o}m, {Claus T.} and Correll, {Christoph U.} and Tina Vilsb{\o}ll and Anders Fink-Jensen",
year = "2017",
language = "English",
pages = "53--54",
booktitle = "DES {\AA}rsm{\o}de 2017",
note = "Dansk Endokrinologisk Selskabs {\AA}rsm{\o}de ; Conference date: 27-01-2017 Through 28-01-2017",
}